Patents by Inventor Mary Katherine Hart

Mary Katherine Hart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOREACTIVE FRANCISELLA TULARENSIS ANTIGENS
    Publication number: 20130184168
    Abstract: The present invention relates to immunoreactive Francisella tularensis antigens and their uses as correlates of protection against tularemia. In one aspect, the invention provides a set of biomarkers for tularemia. In another aspect the invention provides a method of evaluating immunity against tularaemia in a subject, using the biomarkers.
    Type: Application
    Filed: January 13, 2012
    Publication date: July 18, 2013
    Inventors: Mary Katherine HART, Robert Victor HOUSE, Shannon MARTIN
  • peptides and immunogenic compositions containing same
    Patent number: 7267823
    Abstract: Using CTL epitopes to the Ebola GP, NP, VP24, VP30, VP35 and VP40 virion proteins, a method and composition for use in inducing an immune response which is protective against infection with Ebola virus is described.
    Type: Grant
    Filed: March 10, 2003
    Date of Patent: September 11, 2007
    Assignee: United States of America as Represented by the Secretary of the Army
    Inventors: Mary Katherine Hart, Julie Ann Wilson, Gene Garrard Olinger, Jr., Michael Adam Bailey
  • Ebola peptides and immunogenic compositions containing same
    Publication number: 20030224015
    Abstract: Using CTL epitopes to the Ebola GP, NP, VP24, VP30, VP35 and VP40 virion proteins, a method and composition for use in inducing an immune response which is protective against infection with Ebola virus is described.
    Type: Application
    Filed: March 10, 2003
    Publication date: December 4, 2003
    Inventors: Mary Katherine Hart, Julie Ann Wilson, Gene Garrard Olinger, Michael Adam Bailey
  • Overcoming interference in alphavirus immune individuals
    Patent number: 6261567
    Abstract: In this application is described a method for overcoming alphavirus vaccine interference in alphavirus-immune subjects by administration of a second alphavirus vaccine which is altered such that it is not accessible to interfering antibodies. Examples of such alterations are described as well as evidence showing that alphavirus interference likely results from the binding of interfering antibodies to viral proteins expressed on infected cells thereby causing lysis of infected cells.
    Type: Grant
    Filed: May 20, 1998
    Date of Patent: July 17, 2001
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Mary Katherine Hart, Maryam Azarion